0001093557-16-000667.txt : 20160826
0001093557-16-000667.hdr.sgml : 20160826
20160826164942
ACCESSION NUMBER: 0001093557-16-000667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160824
FILED AS OF DATE: 20160826
DATE AS OF CHANGE: 20160826
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Balo Andrew K
CENTRAL INDEX KEY: 0001323190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 161855277
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 5555 OBERLIN DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-08-24
0
0001093557
DEXCOM INC
DXCM
0001323190
Balo Andrew K
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
EVP, Clinical and Regulatory
Common Stock
2016-08-24
4
M
0
5000.0
3.19
A
134979
D
Common Stock
2016-08-24
4
S
0
5000.0
91.72
D
129979
D
Non-Qualified Stock Option (right to buy)
3.19
2016-08-24
4
M
0
5000.0
91.72
D
2009-12-11
2018-12-11
Common Stock
5000
4999
D
On December 11, 2015, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.
Included in this number are 86,333 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 31,666 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 16,667 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
CONFIRMING STATEMENT: This Statement confirms that the undersigned Andrew K. Balo, has authorized and designated Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Jess Roper, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: August 25, 2016 /s/ ANDREW BALO Andrew Balo
By: Kevin Sun For: Andrew K. Balo
2016-08-26